Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Colloidal iodine** is a nonproprietary name used for iodine-containing preparations marketed in multiple formulations, including oral solution, injection, and ophthalmic products, and also for some dietary supplement products containing elemental iodine or iodide. In the context provided, it most plausibly refers to small-molecule iodine preparations associated with JCI Colloidal Iodine Laboratory products rather than a single well-defined approved drug product. Pharmacologically, iodine acts as an iodine replacement source and, in topical or local-use contexts, can exert nonspecific antimicrobial and protein-denaturing effects, but the specific therapeutic indication, formulation standardization, and regulatory status of products sold as colloidal iodine are unclear and heterogeneous. The products described in the source context were identified as unapproved products not established by FDA as safe and effective, so this term should be treated as an ambiguous product name rather than a single clinically standardized medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on colloidal iodine.